Vis enkel innførsel

dc.contributor.authorGundersen, Guri Holmen
dc.contributor.authorNorekvål, Tone M.
dc.contributor.authorGraven, Torbjørn
dc.contributor.authorHaug, Hilde Haugberg
dc.contributor.authorSkjetne, Kyrre
dc.contributor.authorKleinau, Jens Olaf
dc.contributor.authorGustad, Lise
dc.contributor.authorDalen, Håvard
dc.date.accessioned2018-01-02T14:35:16Z
dc.date.available2018-01-02T14:35:16Z
dc.date.created2017-03-22T14:47:47Z
dc.date.issued2017
dc.identifier.citationBMJ Open. 2017, 7:e013734 (3), 1-8.nb_NO
dc.identifier.issn2044-6055
dc.identifier.urihttp://hdl.handle.net/11250/2474137
dc.description.abstractObjectives We aimed to study whether patient-reported outcomes, measured by quality of life (QoL) and functional class, are sensitive to pleural effusion (PLE) in patients with heart failure (HF), and to study changes in QoL and functional class during follow-up of PLE. Methods A cohort of 62 patients from an outpatient HF clinic was included. The amount of PLE was quantified using a pocket-sized ultrasound imaging device. Self-reports of QoL and functional class were collected using the Minnesota Living with Heart Failure Questionnaire (MLHFQ) and the New York Heart Association (NYHA) functional classification. Results At baseline, 26 (42%) patients had PLE of which 19 (31%) patients had moderate to severe amounts of PLE. Patients with no to mild PLE had a lower MLHFQ score (mean 42, SD 21) compared with patients with a moderate to severe amount of PLE (mean 55, SD 24), p=0.03. For 28 patients (45%) with follow-up data, we observed a linear improvement of the MLHFQ-score (3.2, 95% CI 1.2 to 5.1) with each centimetre reduction of PLE. Correspondingly, patient-reported NYHA-class followed the same pattern as the MLHFQ-score. Conclusions Our study indicates that patient-reported outcome measures as MLHFQ may be sensitive tools to identify patients with HF at highest risk of symptomatic PLE and that treatment targeting reduction of PLE during follow-up is essential to improvement of QoL and functional capacity of outpatients with HF.nb_NO
dc.language.isoengnb_NO
dc.publisherBMJ Publishing Groupnb_NO
dc.relation.urihttp://bmjopen.bmj.com/content/7/3/e013734
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/deed.no*
dc.titlePatient-reported outcomes and associations with pleural effusion in outpatients with heart failure: an observational cohort studynb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber1-8nb_NO
dc.source.volume7:e013734nb_NO
dc.source.journalBMJ Opennb_NO
dc.source.issue3nb_NO
dc.identifier.doi10.1136/bmjopen-2016-013734
dc.identifier.cristin1460389
dc.relation.projectNorges forskningsråd: 237887nb_NO
dc.description.localcodeCopyright 2017 the Author(s). Published by the BMJ Publishing Group Limited. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/nb_NO
cristin.unitcode194,65,30,0
cristin.unitcode194,65,25,0
cristin.unitnameInstitutt for nevromedisin og bevegelsesvitenskap
cristin.unitnameInstitutt for sirkulasjon og bildediagnostikk
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse-Ikkekommersiell 4.0 Internasjonal